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This did not include liver disease. The mechanisms for these disparities are unknown, but may include physical barriers (ie, distance traveled for specialized health care). 1 The management of patients with chronic liver failure (CLF) encompasses a spectrum of care: (1) managing complications of portal hypertension, (2) screening and treating hepatocellular carcinoma (HCC), and (3) caring for acutely ill inpatients. Liver disease management is superior when led by an expert in liver disease at a specialized center, almost always a liver transplant (LT) center in a large urban community. [2] [3] [4] [5] [6] For patients with CLF eligible for a LT, rural/urban status and distance to a LT center are associated with less waitlisting and transplantation. [7] [8] [9] [10] However, no population-based studies have evaluated the association between geographic isolation and survival in patients with CLF, important because fewer than 1 in 6 are waitlisted, and fewer than 1 in 12 is transplanted.
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Methods
This was a retrospective cohort study using the HealthCore Integrated Research Database from January 1, 2006, to June 30, 2014, of patients with CLF aged 18-75 years, without exclusionary conditions for LT, as previously described. 11 CLF was defined as cirrhosis plus HCC and/or a complication of portal hypertension, and absent these, laboratory data signifying considerable synthetic dysfunction (bilirubin 3 mg/dL or Model for End-Stage Liver Disease score 15).
11-13
We evaluated overall survival using Cox regression, with follow-up beginning on the date of CLF diagnosis. Transplant-free survival was assessed using competingrisk models (outcome: death; competing risk: transplant). The primary exposure was distance from the centroid of a patient's zip code to the closest LT center. Based on the data's distribution and the relationship between distance and access to LT care from prior studies, distance was modeled as a categorical variable (primary analyses), and continuous for secondary analyses. 7, 11 Study covariates included time-varying stage of cirrhosis and HCC, age, sex, Charlson comorbidity index, etiology of liver disease, and rural/urban status.
11 Transplant access-related variables in a local geographic area included number of LT centers, waitlisting rates, organ supply/demand, number of gastroenterologists, and zip-code level poverty.
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Results
Among 16,824 patients with CLF, 879 (5.2%) lived >150 miles from the closest LT center. The characteristics of patients based on distance categories were balanced (Table 1) . In multivariable models that included etiology of liver disease, patients living >150 miles from the closest LT center had significantly higher mortality (hazard ratio, 1.20; 95% confidence interval [CI], 1.08-1.33; P < .001) and transplant-free mortality (subhazard ratio, 1.18; 95% CI, 1.06-1.32; P ¼ .003). Increasing distance was associated with higher overall (hazard ratio, 1.02; 95% CI, 1.003-1.04; P ¼ .02) and transplant-free (subhazard ratio, 1.03; 95% CI, 1.01-1.04; P ¼ .001) mortality with distance modeled as a continuous variable per unit increase in 50 miles. The association between distance and survival was evident for decompensated cirrhosis or HCC. Although patients living >150 miles from an LT center had fewer outpatient gastroenterologist visits ( not affect the final models. Inclusion of rural/urban status did not attenuate the association between distance and survival; rural status was not associated with increased mortality after adjusting for distance. Zip-code level poverty was not associated with survival (P ¼ .6).
Discussion
For patients with CLF, transplant remains the only option for long-term survival. Yet for the 11 out of 12 who are never transplanted, 8 access to specialized care may still prolong life. Management of complications of cirrhosis is superior with improved survival when led by a gastroenterologist/hepatologist as part of a transplant center's multidisciplinary team. 5, 9, 13 This would seem to explain the disparities in survival for geographically isolated patients with CLF (future work should include patient-level socioeconomic variables), even accounting for access to transplantation, and has important policy implications.
According to Centers for Disease Control and Prevention data, age-adjusted death rates from liver disease from 2010 to 2014 are lowest in New York, where the entire population lives within 150 miles of 1 LT center. By contrast, New Mexico and Wyoming have the highest age-adjusted death rates, and >95% of those states' populations live >150 miles from an LT center. The management of most patients with CLF is not centered on transplantation, but rather the spectrum of care for decompensated cirrhosis and HCC. Thus maintaining access to specialized liver care is important for patients with CLF. Although these associations do not prove cause and effect, they highlight the need for considering the broader impact of transplant-related policies that could decrease transplant volumes and threaten closures of smaller LT centers that serve geographically isolated populations in the Southeast and Midwest. 
